This company is no longer active
Zosano Pharma Future Growth
Future criteria checks 0/6
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 16.5% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Can Zosano Pharma (NASDAQ:ZSAN) Afford To Invest In Growth?
Nov 02Is Zosano Pharma (NASDAQ:ZSAN) Weighed On By Its Debt Load?
Jun 29Data supports long-term benefit of Zosano's migraine candidate; shares surge 23%
May 26Zosano Pharma: Early PK+Safety Study In Q3 2021 May Breathe New Life Into This Biotech
Apr 30Zosano shares rise on migraine treatment NDA resubmission update
Apr 26Auditors Have Doubts About Zosano Pharma (NASDAQ:ZSAN)
Mar 15Zosano Pharma up 21% following FDA feedback on Qtrypta application; presents Qtrypta data in migraine
Feb 01Zosano Pharma requests FDA meeting for its Qtrypta application
Jan 04Zosano Pharma EPS misses by $0.01
Nov 13In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Zosano Pharma has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2022 | 1 | -55 | -31 | -29 | N/A |
12/31/2021 | 1 | -30 | -33 | -28 | N/A |
9/30/2021 | 1 | -31 | -34 | -28 | N/A |
6/30/2021 | 1 | -31 | -39 | -31 | N/A |
3/31/2021 | 0 | -33 | -41 | -31 | N/A |
12/31/2020 | 0 | -33 | -40 | -32 | N/A |
9/30/2020 | N/A | -34 | -41 | -33 | N/A |
6/30/2020 | N/A | -35 | -43 | -33 | N/A |
3/31/2020 | N/A | -37 | -45 | -36 | N/A |
12/31/2019 | N/A | -38 | -47 | -35 | N/A |
9/30/2019 | N/A | -39 | -46 | -34 | N/A |
6/30/2019 | N/A | -37 | -43 | -33 | N/A |
3/31/2019 | N/A | -37 | -40 | -30 | N/A |
12/31/2018 | N/A | -35 | -35 | -29 | N/A |
9/30/2018 | N/A | -33 | -33 | -28 | N/A |
6/30/2018 | N/A | -32 | -30 | -27 | N/A |
3/31/2018 | N/A | -30 | -28 | -26 | N/A |
12/31/2017 | N/A | -29 | -28 | -27 | N/A |
9/30/2017 | N/A | -29 | -29 | -28 | N/A |
6/30/2017 | N/A | -29 | -27 | -26 | N/A |
3/31/2017 | N/A | -29 | -24 | -24 | N/A |
12/31/2016 | N/A | -30 | -26 | -26 | N/A |
9/30/2016 | N/A | -30 | -26 | -25 | N/A |
6/30/2016 | N/A | -31 | -28 | -27 | N/A |
3/31/2016 | 0 | -32 | -28 | -27 | N/A |
12/31/2015 | 0 | -28 | N/A | -24 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if ZSAN.Q's forecast earnings growth is above the savings rate (2%).
Earnings vs Market: Insufficient data to determine if ZSAN.Q's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if ZSAN.Q's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if ZSAN.Q's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if ZSAN.Q's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ZSAN.Q's Return on Equity is forecast to be high in 3 years time